Note: Ingredients listed on restricted chemical lists
EC/CAS
96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
N/A
EC/CAS
202-496-6
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
N/A
General Information
Revision date
2017-05-08
Product name
Everbuild Silicone 900N
Emergency telephone
0044 113 240 3456 (office hours only
Icons in SDS
Company Information
company name
Everbuild - A Sika Company
e-mail address of the competent person responsible for the Safety Data Sheet
everbuild.sds@uk.sika.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319, H351, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Type of product : Mixture
CLP CLASSIFICATION
Eye irritation, Category 2 H319: Causes serious eye irritation. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Chronic aquatic toxicity, Category 3 H412: Harmful to aquatic life with long lasting ef- fects.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H351 Suspected of causing cancer. H412 Harmful to aquatic life with long lasting ef- fects.
Prevention
P201 Obtain special instructions before use. P261 Avoid breathing dust/ fume/ gas/ mist/ va- pours/ spray. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical ad- vice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Hazardous Ingredients
245-366-4 butan-2-one O,O',O''-(methylsilylidyne)trioxime • Pentamethyl piperidylsebacate • 202-496-6 2-butanone oxime • 218-747-8 butan-2-one O,O',O''-(vinylsilylidyne)trioxime
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
